Login to Your Account

Another Earnings Home Run: Genentech 'Can Do No Wrong'

By Randall Osborne

Friday, July 11, 2003
With a 23 percent increase in product sales, Genentech Inc. chalked up earnings in the second quarter of 31 cents per share, a 35 percent jump in EPS, figured on a non-GAAP (generally accepted accounting principles, formerly known as pro forma) basis. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription